HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inger S Nijhof Selected Research

Disease Progression

12/2021Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Inger S Nijhof Research Topics

Disease

20Multiple Myeloma
01/2022 - 01/2012
4Neoplasms (Cancer)
01/2022 - 01/2012
1Lymphoma (Lymphomas)
01/2022
1Bronchiolitis Obliterans Syndrome
01/2022
1COVID-19
01/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022
1Disease Progression
12/2021
1Cytokine Release Syndrome
11/2020
1Bites and Stings (Sting)
11/2020
1Chromosome Aberrations (Chromosome Abnormalities)
11/2016
1Exanthema (Rash)
01/2012
1Thrombocytopenia (Thrombopenia)
01/2012
1Fatigue
01/2012
1Neutropenia
01/2012

Drug/Important Bio-Agent (IBA)

12daratumumabIBA
12/2021 - 02/2015
7Lenalidomide (CC 5013)FDA Link
09/2018 - 01/2012
4Monoclonal AntibodiesIBA
10/2020 - 06/2015
3AntibodiesIBA
10/2020 - 01/2018
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2021
2ixazomibIBA
01/2021 - 01/2018
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 12/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2018 - 11/2016
2Prednisone (Sone)FDA LinkGeneric
09/2018 - 11/2016
2Bortezomib (Velcade)FDA Link
11/2016 - 06/2015
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1ibrutinibIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1ruxolitinibIBA
01/2022
1Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2021
1EpitopesIBA
01/2021
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
11/2020
1tocilizumab (atlizumab)FDA Link
11/2020
1SteroidsIBA
11/2020
1Bispecific AntibodiesIBA
11/2020
1B-Cell Maturation AntigenIBA
11/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1IgG Receptors (Fc gamma RI)IBA
01/2019
1carfilzomibIBA
01/2018
1pomalidomideIBA
01/2018
1elotuzumabIBA
01/2018
1Histone Deacetylase InhibitorsIBA
01/2018
1Proteasome InhibitorsIBA
01/2018
1PanobinostatIBA
01/2018
1Complement System Proteins (Complement)IBA
12/2017
1Thalidomide (Thalomid)FDA Link
01/2012

Therapy/Procedure

4Therapeutics
01/2022 - 06/2015
2Drug Therapy (Chemotherapy)
01/2022 - 06/2015
1Cell Transplantation
01/2022